Media

ChemDiv today announced the continued expansion of its Modeling & Simulation Services platform, highlighted by the signing of its tenth collaborator in 2026, Mondego Bio (Coimbra, Portugal), f...

Explore the new frontier of RNA Inhibitors and small molecules targeting RNA. Discover mechanisms, scientific validation, and purchase specialized screening libraries at ChemDiv.

We are passionate about the latest trends in life sciences and medicinal chemistry and closely monitoring the latest developments and discoveries in this area. It means a lot to us if our custome...

Hemab Therapeutics shares promising Phase I/II clinical trial data for subcutaneous HMB-002, demonstrating reduced bleeding in Von Willebrand Disease.

Neurophysiology Kelava, I., Chiaradia, I., Pellegrini, L. et al. Androgens increase excitatory neurogenic potential in human brain organoids. Nature 602, 112–116 (2022) Sex-based brain dif...